Keywords: پاسخ عمده مولکولی; AA; accelerated approval; ALL; acute lymphoblastic leukemia; CCyR; complete cytogenetic response; CLL; chronic lymphocytic lymphoma; CML; chronic myeloid leukemia; CRC; colorectal carcinoma; CR; complete response; CRi; complete response with incomplete bl
مقالات ISI پاسخ عمده مولکولی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پاسخ عمده مولکولی; AE; adverse event; ALL; acute lymphoblastic leukemia; alloSCT; allogeneic hematopoietic stem cell transplant; AYA; adolescent and young adult; BFM; Berlin-Frankfurt-Münster; CAR-T; chimeric antigen receptor-modified T cell; CCyR; complete cytogenetic r
Keywords: پاسخ عمده مولکولی; Tyrosine kinase inhibitors; Drug transporter; Drug interaction; Therapeutic drug monitoring; Skin disorders; ADR; Adverse drug reaction; AUC; Area under the curve; BBB; Blood-brain barrier; BCRP/ABCG2; Breast cancer resistance protein; CNS; Central nerv
Keywords: پاسخ عمده مولکولی; chronic myeloid leukemia; complete cytogenetic response; dasatinib; health technology assessment; HTA; imatinib; intermediate outcomes; major molecular response; nilotinib; surrogate end points; systematic review; technology appraisal;
Identification of chronic myeloid leukemia patients treated with imatinib who are potentially eligible for treatment discontinuation by assessing real-life molecular responses on the international scale in a EUTOS-certified lab
Keywords: پاسخ عمده مولکولی; CML; chronic myeloid leukemia; CML-CP; chronic myeloid leukemia in chronic phase; DMR; deep molecular response; ELN; European LeukemiaNet; ENESTFreedom; Evaluating Nilotinib Efficacy and Safety in Clinical Trials - Following REsponsE in De nOvo CML-CP P
Impact of the BCR-ABL1 fusion transcripts on different responses to Imatinib and disease recurrence in Iranian patients with Chronic Myeloid Leukemia
Keywords: پاسخ عمده مولکولی; CML; Chronic Myeloid Leukemia; IM; imatinib mesylate; PB; peripheral blood; CP; chronic phase; AP; accelerated phase; BP; blastic phase; MCR; major cytogenetic response; CCR; complete cytogenetic response; MMR; major molecular response; CMR; complete mole
PharmacogenomicsGenetic variations of hOCT1 gene and CYP3A4/A5 genes and their association with imatinib response in Chronic Myeloid Leukemia
Keywords: پاسخ عمده مولکولی; CML; Chronic Myeloid Leukemia; CP; chronic phase; CCyR; Complete Cytogenetic Response; MMR; Major Molecular Response; MCyR; Major Cytogenetic Response; CHR; Complete Haematological Response; SNP; single nucleotide polymorphism; hOCT1; human organic cation
Monitoring of response to therapy with imatinib mesylate in Chronic Myeloid Leukemia in chronic phase (CML-CP)
Keywords: پاسخ عمده مولکولی; CML-CP; Imatinib mesylate; Major molecular response; RQ-PCR
Major molecular response during the first year of dasatinib, imatinib or nilotinib treatment for newly diagnosed chronic myeloid leukemia: A network meta-analysis
Keywords: پاسخ عمده مولکولی; Chronic myeloid leukemia; Comparative effectiveness; Network meta-analysis; Major molecular response; Nilotinib; Dasatinib; Imatinib;
Molecular Resistance: An Early Indicator for Treatment Change?
Keywords: پاسخ عمده مولکولی; BCR-ABL inhibitor; Imatinib intolerance or resistance; Major molecular response; Monitoring response; Treatment failure
Suboptimal Response to or Failure of Imatinib Treatment for Chronic Myeloid Leukemia: What Is the Optimal Strategy?
Keywords: پاسخ عمده مولکولی; CCyR; complete cytogenetic response; CHR; complete hematologic response; CML; chronic myeloid leukemia; CP; chronic phase; ELN; European LeukemiaNet; IRIS; International Randomized Study of Interferon vs STI571; MCyR; major cytogenetic response; MMR; majo
Chronic Myeloid Leukemia: Diagnosis and Treatment
Keywords: پاسخ عمده مولکولی; ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; AP; accelerated phase; ATP; adenosine triphosphate; BP; blast phase; CCGR; complete cytogenetic response; CHR; complete hematologic response; CML; chronic myeloid leukemia; CP; chronic phase;